- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.04. | Envision appoints Darren Coleman as Executive VP, Chief Information Officer | ||
| 23.04. | AL-S Pharma release new data from AP-101 phase 2 trial for ALS | ||
| 23.04. | Envision appoints Jay Ferro as President, Technology and Chief Product Officer | ||
| 22.04. | Grifols share results identifying early signs of Parkinson's disease | ||
| 22.04. | Richmond Pharmacology appoints John Hotti as Chief Technology Officer | ||
| 21.04. | Shionogi starts phase 2 clinical trial for Pompe Disease | ||
| 21.04. | Clasado appoints Sebastian Nummelin as new APAC Regional Director | ||
| 20.04. | Astellas' application to EMA validated for treatment of muscle-invasive bladder cancer | ||
| 20.04. | CNX Therapeutics appoints David Flint as Chief Corporate Development Officer | ||
| 17.04. | Potential US-Iran peace deal to redraw market winners and losers | ||
| 17.04. | Sumitomo Pharma's stem cell therapy for Parkinson's given limited approval in Japan | ||
| 17.04. | Allergan Aesthetics launches Skin Quality Index for aesthetic consultations | ||
| 16.04. | AC Immune amends agreement with Lilly to develop potential Alzheimer's treatment | ||
| 16.04. | Bowel Research UK appoints Kathryn Pretzel-Shiels as CEO | ||
| 15.04. | EMA's PRIME scheme launches three major new features | ||
| 14.04. | Annovis partners with NeuroRPM on new AI platform to track Parkinson's symptoms | ||
| 14.04. | START partners with Trialing to expand patient access to oncology clinical trials across Europe | ||
| 13.04. | Bristol Myers Squibb evolves and expands multiple myeloma programme | ||
| 13.04. | One-carbon Therapeutics collaborates with Tempus in cancer treatment | ||
| 10.04. | Lilly to acquire Centessa in deal worth up to $7.8bn | ||
| 10.04. | Takeda's CEO-elect, Julie Kim, proposed as new candidate for Board of Directors | ||
| 09.04. | Biogen to acquire Apellis in $5.6bn deal | ||
| 09.04. | Matt Ferriday announced as General Manager for LEO Pharma UK | ||
| 08.04. | Gilead to acquire Tubulis for up to $5bn | ||
| 08.04. | Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.